2021 FDA approvals

The FDA approved 50 novel drugs in 2021, including the first KRAS inhibitor for cancer and the first anti-amyloid antibody for Alzheimer’s disease.The FDA approved 50 novel drugs in 2021, including the first KRAS inhibitor for cancer and the first anti-amyloid antibody for Alzheimer’s disease.

Saved in:
Bibliographic Details
Published inNature reviews. Drug discovery Vol. 21; no. 2; pp. 83 - 88
Main Author Mullard, Asher
Format Journal Article
LanguageEnglish
Published England Nature Publishing Group 01.02.2022
Subjects
Alzheimer's disease
Drug Approval - statistics & numerical data
FDA approval
Humans
United States
United States Food and Drug Administration
United States
Online AccessGet full text

Cover

More Information
Summary:The FDA approved 50 novel drugs in 2021, including the first KRAS inhibitor for cancer and the first anti-amyloid antibody for Alzheimer’s disease.The FDA approved 50 novel drugs in 2021, including the first KRAS inhibitor for cancer and the first anti-amyloid antibody for Alzheimer’s disease.
Bibliography:SourceType-Other Sources-1
ObjectType-News-1
content type line 66
ISSN:1474-1776
1474-1784
DOI:10.1038/d41573-022-00001-9